A hallmark of PDAC is its abundant and complex tumor stroma which not only supports tumor progression but also forms a major barrier to effective treatment. Conventional therapies including chemotherapy and even the most advanced immunotherapies have shown limited clinical benefit for many patients.
This position offers a unique opportunity to contribute to impactful research that may ultimately improve outcomes for patients with pancreatic cancer.
As a PhD candidate you will:
You will be embedded in a dynamic and international research group at Department of Medical Biosciences Radboud university medical center (Radboudumc) in Nijmegen a leading center for patient care biomedical research and education. The hosting department has strong expertise in cancer biology translational oncology and drug development and provides access to state-of-the-art facilities and core platforms.
You will work in a collaborative environment where basic scientists and clinicians closely interact enabling real translational impact. The team consists of motivated PhD candidates postdocs technicians and clinician-scientists who support each others development and success.
Medical BioSciences is a science department where fundamental and translational biomedical research come together. You will study disease and health from the molecular level to clinical application with a strong focus on medical innovation. Researchers work closely with clinicians to translate new insights into better diagnostics and treatments. Using experimental and data-driven approaches we study biochemical cellular and physiological processes in health and disease.
About the company Bij het Radboudumc bouw je aan de toekomst. Of je hart nu ligt bij zorg, onderzoek of onderwijs, bij ons kom je verder. We gaan voor de beste zorg. Dat maken we waar omdat je je bij ons ontwikkelt, kansen pakt en ruimte voelt om op te staan. Ben jij er klaar voor om ... View more